1987
DOI: 10.1016/s0022-2828(87)80572-2
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac specific troponin-I release in canine experimental myocardial infarction: Development of a sensitive enzyme-linked immunoassay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
40
0
1

Year Published

1992
1992
2015
2015

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 80 publications
(42 citation statements)
references
References 37 publications
1
40
0
1
Order By: Relevance
“…Concentrations begin to increase and peak at 12–48 hours and then decrease after 5–10 days 31. A canine model of acute myocardial infarction showed similar release times, but the peak occurred earlier (range, 10–16 hours) 32. A study of dogs with GDV identified peak serum cTnI concentrations between 48 and 72 hours, after surgery.…”
mentioning
confidence: 93%
“…Concentrations begin to increase and peak at 12–48 hours and then decrease after 5–10 days 31. A canine model of acute myocardial infarction showed similar release times, but the peak occurred earlier (range, 10–16 hours) 32. A study of dogs with GDV identified peak serum cTnI concentrations between 48 and 72 hours, after surgery.…”
mentioning
confidence: 93%
“…10 The similarity of the canine heart to the human heart has resulted in the use of dogs as an experimental model for induced myocardial infarction, in which cTnT and cTnI have been found to be sensitive and specific biomarkers of cardiac injury. [13][14][15][16][17] A limited number of clinical studies on cardiac troponins in dogs have been published in recent years. [18][19][20][21][22][23] Results of these studies indicate that cardiac troponins may be helpful in the identification of myocardial contusion, myocarditis, and congestive heart failure, doxorubicin-induced cardiotoxicity, and in distinguishing between idiopathic pericardial effusion and pericardial effusion caused by hemangiosarcoma.…”
mentioning
confidence: 99%
“…However, the correlation between serum Tm or TnT levels and infarct size has not been examined, 5,6 and release of TnI did not always correlate well with infarct size. 8 Although the appearance of myofibrillar proteins in serum indicates that these proteins were degraded within the heart during myocardial ischemia, these studies provide little information about changes in myofibrillar proteins and their inherent function within the heart.…”
mentioning
confidence: 99%